{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-017314","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.047999+00:00","generated_at":"2026-05-27T05:44:17.649452+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CEO Terry Weber retires; Bret Christensen named new CEO effective Feb 1, 2025","bullets":["Terry Weber resigns as CEO and director, effective Feb 1, 2025; becomes Strategic Advisor.","Bret Christensen named CEO and director; formerly CEO of DermTech and CCO at Insulet.","Christensen receives $700k base salary, up to 85% bonus, 1.5M share option grant, $200k relocation.","Weber receives $621,700 severance and $20k/month consulting fee through Feb 2026.","Weber's equity awards continue vesting through later of consulting term end or Feb 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-017314","json":"https://secwatch.observer/filing/0001193125-25-017314.json","markdown":"https://secwatch.observer/filing/0001193125-25-017314.md","text":"https://secwatch.observer/filing/0001193125-25-017314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312525017314/0001193125-25-017314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312525017314/d776515d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:44:17.649452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"248c3f5085","claim":"Bret Christensen was appointed as Chief Executive Officer at biote Corp..","evidence_excerpt":"appointed Bret Christensen as Chief Executive Officer (principal executive officer) of the Company and as a member of the Board to fill the vacancy created by Ms. Weber’s resignation, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312525017314/0001193125-25-017314-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"ff3e789129","claim":"Teresa S. Weber resigned as Chief Executive Officer at biote Corp..","evidence_excerpt":"accepted the resignation of Teresa S. Weber, the Company’s Chief Executive Officer, from all positions she holds with the Company, including stepping down from the Board, effective as of February 1, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312525017314/0001193125-25-017314-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}